Latest news and articles about prostate cancer from NEX English
A recent study reveals that the diabetes medication Metformin may mimic the benefits of exercise for prostate cancer patients, opening new avenues for treatment. This discovery could significantly impact disease management and improve patients' quality of life.
Researchers at the Massey Comprehensive Cancer Center have developed a new drug aimed at preventing the spread of prostate cancer to the bones, potentially changing treatment approaches for this serious disease affecting millions of men worldwide.
A recent clinical study at the cancer treatment center in Los Angeles reveals promising outcomes for recurrent prostate cancer using targeted PSMA nuclear therapy. This could revolutionize available treatment options.
A new study reveals that PSMA treatment can postpone the need for hormonal therapy in patients with early prostate cancer, offering new hope for improved treatment options. This breakthrough could significantly change the management of this cancer type.
Recent advancements in routine prostate cancer screenings allow doctors to utilize modern techniques for improved diagnostic accuracy. These developments empower men to make informed health decisions.
A recent study reveals that hormonal replacement therapy patches are as effective as traditional injections in treating prostate cancer in men, with fewer side effects and reduced hospital visits.
A recent British study reveals that hormonal patches, typically used to alleviate menopause symptoms in women, can effectively treat prostate cancer in men. Conducted by researchers at University College London, the study involved 1,360 men with advanced localized prostate cancer.
Fish oil, rich in omega-3 fatty acids, is considered a beneficial supplement for men suffering from prostatitis, aiding in inflammation reduction and overall health improvement.